HPR announces publication of a brain imaging study in a NHP model of unilateral neuropathy.
Keep moving forward
SERVICES
Provide high quality drug efficacy testing for unmet medical needs
Central Nervous System
Pain
Pain
Other
Ophthalmology
Gastroenterology
Hamamatsu Pharma Research (HPR) offers translational research innovations through preclinical efficacy evaluation of novel therapeutics in cynomolgus macaque-based disease models. With HPR's pharmacological expertise and unique approach to preclinical research, HPR will help you boost your research to the next level.
Ideal Preclinical Model Species
Because of the genetic closeness of nonhuman primate to humans, HPR's cynomolgus macaque-based models will add significant value to your preclinical findings.
Neuroimaging of Pain
Stimulus evoked brain activation as a quantifiable outcomemeasure obtained with clinical grade noninvasive neuroimaging.
HPR News
Neuroprotective effect of brimonidine in a NHP model of ocular hypertension.
HPR is virtually attending Korea Pharm & Bio 2021, May 25 - 28. Looking forward to presenting HPR's services!
CONTACT
Please feel free to contact us for more details concerning our NHP models and services.